AllerFund

Venture Capital New York, United States ·Founded 2020

Overview

AllerFund is a venture capital firm focused on investing in early-stage companies that develop treatments, diagnostics, and products for individuals with food allergies. The firm collaborates with scientists and entrepreneurs to build businesses around promising research and technologies, providing critical business advice and support. The firm's investment strategy emphasizes the clinical and community impact of its portfolio companies, aiming to create therapeutic, diagnostic, or tool-based solutions that significantly improve the lives of those with food allergies. AllerFund's portfolio includes investments in therapeutics, medical devices, diagnostics, digital technologies, and consumer products. AllerFund's team comprises experienced professionals specializing in growth-stage investments across technology and healthcare sectors. The firm is known for its data-driven approach and emphasizes strategic partnerships to enhance portfolio value, supporting sustainable scaling and innovation within its investee companies.

Investment Focus

  • Early-stage companies developing solutions for food allergies

Portfolio Companies

ATANIS Biotech AG

Get the full list of 54,000+ investors

AllerFund and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about AllerFund

What sectors does AllerFund invest in?

AllerFund invests in Health Care, Biotechnology, Medical, Health Diagnostics and Personal Health, and is based in New York, United States. AllerFund is listed as a venture capital in the ConnectSafely investor database.

What stage does AllerFund invest at?

AllerFund backs companies at Seed and Series A, writing cheques of 100K - 1M.

Which regions does AllerFund invest in?

AllerFund invests across United States and Germany.

What companies has AllerFund invested in?

AllerFund's portfolio includes ATANIS Biotech AG.

Last updated · Source: ConnectSafely investor database